A seaweed extract has the potential to combat inflammatory bowel disorders, say University of Tasmania researchers.
Their new mice study showed the oral use of fucoidan significantly reduced the symptoms and the pathology of acute colitis.
"Inflammatory bowel disorders such as ulcerative colitis can be debilitating and lead to a significantly decreased quality of life," the scientists said.
Their study, published in the journal PLOS ONE, said current treatments for ulcerative colitis are often costly and may have limited efficacy.
Fucoidan was found to significantly reduce underlying intestinal inflammation, and reduce weight loss, a common and often undesirable colitis side effect, by 50 per cent.